Results 91 to 100 of about 2,397 (210)

Orally administered torsemide in horses: pharmacokinetic and pharmacodynamic studies [PDF]

, 2018
Diuretic therapy is the mainstay for management of congestive heart failure in horses. Loop-diuretic medications in horses have been restricted to injectable medications because currently, no data support the use of orally-administered loop diuretics ...
Ferlini Agne, Gustavo
core  

Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review

The American Journal on Addictions, Volume 34, Issue 6, Page 589-602, November 2025.
Abstract Background and Objectives Xylazine, an alpha‐2‐adrenergic agonist, has been increasingly implicated in substance use and overdose crises. However, little is known about its effects on humans. With the growing public health crisis surrounding xylazine, it has become important to recognize and promptly manage symptoms of xylazine toxicity ...
Philipa Owusu‐Antwi, Priya Atodaria, Edmund Appiah‐Kubi, Zainab Shah, Elpidio Marlon Garcia   +4 more
wiley   +1 more source

Toxic epidermal necrolysis associated with combination therapy of spironolactone and torsemide

, 2020
Melcy Mary Philip, Kala Kesavan P, Jai Prakash   +2 more
openalex   +4 more sources

Impact of Baseline Body Mass Index on the Effectiveness and Safety of Torsemide-Spironolactone Fixed-Dose Combination in Indian Patients with Heart Failure: Subgroup Analysis from the Restore-Hf Study

Indian Heart Journal
Chandrashekhar Kashinath Ponde, Devanu Gosh Roy, Arun Mohanty, Uday Jadhav, Karan Dang, Saranraj Kamaraj, Amarnath Sugumaran, Sandesh Sawant, Senthilnathan Mohanasundaram   +8 more
doaj   +2 more sources

Torsemide and Furosemide as Green Inhibitors for the Corrosion of Mild Steel in Hydrochloric Acid Medium

, 2016
The performance of torsemide and furosemide drugs as corrosion inhibitors for mild steel in 1 N HCl was thoroughly investigated by weight loss and electrochemical methods.
Sambantham Karthikeyan (1838653), Sappani Hari Kumar (1952245)   +1 more
core   +1 more source

Rationale and Study Design of Real-World Effectiveness and Safety of Torsemide and Spironolactone Fixed Dose Combination in Indian Heart Failure Patients (RESTORE-HF Study): A Prospective, Longitudinal, Multicentre, Observational Study

, 2023
Chandrashekhar K. Ponde, Devanu Gosh Roy, A. K. Mohanty, D. Chakkravarthi, Nitin Zalte, Amarnath Sugumaran, Senthilnathan Mohanasundaram, Jaideep Gogtay   +7 more
openalex   +1 more source

Association between PCSK9 inhibitors and acute kidney injury: a pharmacovigilance study

Frontiers in Pharmacology
BackgroundPCSK9 inhibitors are a novel class of lipid-lowering medications, and numerous clinical studies have confirmed their significant role in improving the progression of chronic kidney disease.
Hailing Liu
doaj   +1 more source

DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-UPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF TORSEMIDE AND SPIRANOLACTONE IN BULK AND PHARMACEUTICAL DOSAGE FORMS

, 2022
Lalitha Repudi, M. Lakshmi Surekha
openalex   +2 more sources

Clinical evaluation of a novel fixed-dose combination tablet (Sentorpil® ForteGold) versus compounded powdered medications in dogs with myxomatous mitral valve disease: a randomized, double-blind study

Frontiers in Veterinary Science
IntroductionMyxomatous mitral valve disease (MMVD) is a prevalent cardiac condition in older, small-breed dogs, often managed with multiple medications.
Jiyoung Park, Jiyoon Lee, Sang-Joon Lee, Changbaig Hyun   +3 more
doaj   +1 more source

Development of Fast Dissolving Tablets of Torsemide. [PDF]

, 2014
Oral mucosal drug delivery system is widely applicable as novel site for administration of drug for immediate and controlled release action by preventing first pass metabolism and enzymatic degradation due to GI microbial flora.
Ponnammal Asmi, S
core